INFLUENCE OF CpG ODN 2006 OLIGODEOXYNUCLEOTIDE ON CYTOKINE PRODUCTION BY BLOOD CELLS OF HUMANS VACCINATED AGAINST PLAGUE
This study presents data upon the effects of CpG oligonucleotide substance (CpG ODN 2006). The commercial preparation was applied in vitro as a single agent, or in combination with various cytokine production inducers. Spontaneous and induced cytokine levels were tested in cultures of human blood ce...
Saved in:
Main Authors: | S. N. Klyueva, T. P. Shmelkova, T. N. Schukovskaya |
---|---|
Format: | article |
Language: | RU |
Published: |
SPb RAACI
2015
|
Subjects: | |
Online Access: | https://doaj.org/article/2f70e24f59f3496e92f5e4888e657b67 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CpG oligodeoxynucleotide nanomedicines for the prophylaxis or treatment of cancers, infectious diseases, and allergies
by: Hanagata N
Published: (2017) -
Effects of CpG oligodeoxynucleotide 1826 on acute radiation-induced lung injury in mice
by: Li,Xuan, et al.
Published: (2016) -
CpG Oligodeoxynucleotides Attenuate OVA-Induced Allergic Airway Inflammation via Suppressing JNK-Mediated Endoplasmic Reticulum Stress
by: Zhang HY, et al.
Published: (2021) -
Mannose-Modified Liposome Co-Delivery of Human Papillomavirus Type 16 E7 Peptide and CpG Oligodeoxynucleotide Adjuvant Enhances Antitumor Activity Against Established Large TC-1 Grafted Tumors in Mice
by: Zhao Y, et al.
Published: (2020) -
Mannose-Modified Liposome Co-Delivery of Human Papillomavirus Type 16 E7 Peptide and CpG Oligodeoxynucleotide Adjuvant Enhances Antitumor Activity Against Established Large TC-1 Grafted Tumors in Mice [Corrigendum]
by: Zhao Y, et al.
Published: (2021)